Evidence map›Paper›PMID 19687773›Full record

ArticlePediatric research2009

Impact of fish oil-based lipid emulsion on serum triglyceride, bilirubin, and albumin levels in children with parenteral nutrition-associated liver disease.

Sang I Lee, Clarissa Valim, Patrick Johnston, Hau D Le, Jonathan Meisel, Danielle A Arsenault, Kathleen M Gura, Mark Puder

2 registry-linked trialsOpen access · bronzeAbstract readComparative Study
In one paragraph

Article in Pediatric research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01194063 phase3completednot on this mapstarted 2010, after this paper: background citation

Use of Omegaven for Parenteral Nutrition Associated Liver Disease

TypeinterventionalSponsorKapiolani Medical Center For Women & ChildrenRan2010 to 2019Enrolled36ConditionsCholestasisArmsOmega-3 fish oil lipid emulsion
NCT02633384 phase4terminatednot on this mapstarted 2011, after this paper: background citation

Incidence and Severity of Parenteral Nutrition Associated Cholestasis in Neonates Subjected to Major Surgery, Using Two Mixed Intravenous Lipid Emulsions

TypeinterventionalSponsorCentro Hospitalar de Lisboa CentralRan2011 to 2017Enrolled52ConditionsIntrahepatic, CholestasisArmsSMOFlipid, Lipofundin
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. ESPEN guideline on clinical nutrition in liver disease.Clinical nutrition (Edinburgh, Scotland) · 2019
    Guideline
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Observational
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Sang I LeeDepartment of Surgery, Harvard Medical School, 11 Priscilla Road, No. 1, Boston, MA 02135, USA. slee10@bidmc.harvard.edu
Clarissa Valim
Patrick Johnston
Hau D Le
Jonathan Meisel
Danielle A Arsenault
Kathleen M Gura
Mark Puder
Harvard University Press · USBoston Children's Hospital · USHarvard University · US

Funding

Mechanisms of Hepatic Steatosis PreventionK08DK069621 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI PUDER, MARK · 2005 to 2009
$639k
FDA HHS R01 FD003436FDA HHS R01 FD003460NIDDK NIH HHS DK069621-05NIDDK NIH HHS K08 DK069621
6 · The paper itself

Abstract

Parenteral nutrition is known to cause liver injury in babies. The aim of this study is to investigate the effects of different lipid emulsions on parenteral nutrition-associated cholestasis in infants. In addition, there may be a relationship between the lipid emulsion and triglyceride levels. Furthermore, triglyceride levels may correlate with direct bilirubin and albumin, as markers of liver impairment and nutritional status. Patients with parenteral nutrition-associated cholestasis who were treated with a fish oil-based lipid emulsion (n = 18) were prospectively followed for triglyceride, direct bilirubin, and albumin levels and compared with patients who were maintained on a soy-based lipid emulsion (n = 59). Triglyceride levels decreased in the fish oil cohort from a mean of 140 mg/dL at wk 0 to 40 mg/dL at wk 20 but remained unchanged at approximately 140 mg/dL in the soybean cohort. Triglyceride levels of patients treated with fish oil declined over time, while those receiving soybean oil did not. Also, changes in triglyceride levels over time were directly correlated with direct bilirubin and inversely related to albumin levels. These findings may indicate an added benefit of reduced triglyceride levels for patients treated with fish oil and this effect coincides with markers for improved liver function and nutritional status.

Indexed as

BilirubinCholestasisFat Emulsions, IntravenousFish OilsGermanyHumansInfantMassachusettsParenteral NutritionSerum AlbuminStatistics, NonparametricTriglyceridesBilirubinFat Emulsions, IntravenousFish OilsSerum AlbuminTriglycerides

Identifiers

PMID19687773
PMCPMC3377973
OpenAlexW2021050483

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.